Trading activity:
Reported 24-hour volume equals 0.15% of market capitalization. The local markets snapshot lists Kraken among venues with observed trading activity.
YearBull indicators:
YearBull Rank #1,249. Bull Score 81/100.
YB Market Risk Low. This relative market-volatility label is not an investment-safety assessment.
Cycle Early. Observed price change: 24h -3.49% · 7d 0.23% · 30d 6.10%.
Values are descriptive and should be read together rather than as a price forecast.
Read the YearBull methodology.
Snapshot date: 2026-10-27.Data history: 90 days available in the latest 90-day window.
Methodology responsibility:
YearBull’s analytical methodology and presentation rules are developed and maintained by
Alan Zelvin, Founder & Lead Crypto Researcher.
This note identifies responsibility for the methodology; it does not attribute authorship of this data snapshot.
What is Pfizer xStock (PFEX)?
Source description
“"For too long, investing has come with barriers. Borders. Brokers. Limitations. It’s been complicated, costly, and — for millions — out of reach. xStocks were created to change that. xStocks are tokenized stocks. They’re backed 1:1 by the underlying assets, composable with DeFi protocols, compliant with EU regulations, accessible to non-US users, and provide a legal claim to the value of the stock. xStocks enable easy access to 57 US Stocks and ETFs to regular users through top centralized and decentralized exchanges, and can be integrated with other DeFi protocols like any other token."”
This source-supplied description may contain old, promotional, or unverified claims and is not YearBull editorial analysis.
Recorded networks: Arbitrum One, Ethereum, Binance Smart Chain, Solana, The Open Network, Mantle
Official links and contract records appear in Key Facts. Project details can change, so verify current information with the project.
Pfizer xStock (PFEX) FAQ
Which facts establish tokenization for Pfizer xStock (PFEX)?
xStocks documentation describes tokenized representations of public equities and ETFs backed 1:1 by the corresponding underlying asset held with a regulated custodian. Do not present PFEX as ordinary company stock; legal eligibility, issuer terms and current chain deployment require the product-specific Backed/xStocks record.
What information is available about data access for Pfizer xStock (PFEX)?
The xStocks catalog is the official product directory and provides product-level information and contract links; PFEX must be matched to its exact listing before quoting contract or chain data.
Pfizer xStock metric comparison
This comparison is a stored snapshot generated 2026-10-23 06:31 UTC from 293 daily observations available from 2025-12-30 through 2026-10-23. It is separate from the latest analytical cards above. Percentiles compare the snapshot value with that day's analytical universe; a higher percentile means a larger observed value, not necessarily a better investment characteristic.
Metric
Snapshot
30d before
90d before
Change vs 30d
Universe percentile
Price
$30.32
$27.62
$24.06
+9.8%
n/a
Market cap
$362.0K
$348.8K
$307.5K
+3.8%
P53.5
YearBull Rank
#682
#3,552
#1,670
Improved 2,870
P92.0
Bull Score
83/100
58/100
62/100
+25.0 pts
P97.0
Turnover
0.32%
0.15%
1.00%
+0.2 pts
P43.6
YB Market Risk
Low
Low
Low
Unchanged
n/a
Cycle
Early
Early
Early
Unchanged
n/a
Median absolute daily movement 0.59%; distance from the highest local daily price -0.9%; circulating supply change -51.0%. These measurements are descriptive and do not predict future direction.
Editorial research. Identity, project facts, sources, and risks below belong to the dated editorial review. The live analytical snapshot above may be newer and is generated separately from stored market data.
Pfizer xStock: project profile and documented design
xStocks documentation describes tokenized representations of public equities and ETFs backed 1:1 by the corresponding underlying asset held with a regulated custodian.
Documented role and design
The xStocks catalog is the official product directory and provides product-level information and contract links; PFEX must be matched to its exact listing before quoting contract or chain data.
Risks and open questions
Do not present PFEX as ordinary company stock; legal eligibility, issuer terms and current chain deployment require the product-specific Backed/xStocks record.
YearBull Rank update
Newest YearBull Rank value for pfizer-xstock: #1249.
Rank timeline (last 365 days)
Rank change (nearest points).
Reading rule: lower numbers mean higher placement.
7d window (2026-10-21): #1296 → #1249 (up by 47).
30d window (2026-09-28): #1857 → #1249 (up by 608).
YearBull Rank is a relative ranking on YearBull designed to compare coins on a common scale and time window. Use it as positioning context over time, not as a promise.
Market access: If rank moves sharply, it may reflect venue mix changes rather than fundamentals.
Risk view: If it improves then retraces fast, treat it as rotation pressure.
Cycle view: If the line is range-bound, treat changes as relative, not absolute.
Liquidity framing: If the line flatlines, the coin may be moving with its liquidity peers.
Editorial note:
This analysis was prepared by the YearBull research team under the direction of
Alan Zelvin,
Founder and Lead Crypto Researcher.
The assessment follows YearBull’s internal research methodology and editorial standards.
Methodology ·
Editorial Policy
Related Research
Continue with contextually connected profiles and category data:
Stored venue snapshot. Markets last checked: 2026-07-27. Updated on a rolling basis; no fixed refresh date is promised. Venue listings and volumes are stored snapshots, not live quotes.
